Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease


Autoria(s): Lienert, Carmen; Schawalder, Gabriela; Findling, Oliver; Kamm, Christian P.; Humpert, Sebastian; Mugglin, Anne; Mathis, Johannes; Sturzenegger, Matthias; Mattle, Heinrich P.
Data(s)

01/05/2013

Resumo

In Switzerland, the first course of intravenous steroids for treatment of episodes of demyelinating CNS disease is usually administered in an inpatient setting. We prospectively evaluated short term tolerance of treatment with special emphasis on sleep quality.

Formato

application/pdf

Identificador

http://boris.unibe.ch/15951/1/smw-2013-13783.pdf

Lienert, Carmen; Schawalder, Gabriela; Findling, Oliver; Kamm, Christian P.; Humpert, Sebastian; Mugglin, Anne; Mathis, Johannes; Sturzenegger, Matthias; Mattle, Heinrich P. (2013). Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease. Swiss medical weekly, 143, w13783. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13783 <http://dx.doi.org/10.4414/smw.2013.13783>

doi:10.7892/boris.15951

info:doi:10.4414/smw.2013.13783

info:pmid:23740464

urn:issn:1424-7860

Idioma(s)

eng

Publicador

EMH Schweizerischer Ärzteverlag

Relação

http://boris.unibe.ch/15951/

Direitos

info:eu-repo/semantics/openAccess

Fonte

Lienert, Carmen; Schawalder, Gabriela; Findling, Oliver; Kamm, Christian P.; Humpert, Sebastian; Mugglin, Anne; Mathis, Johannes; Sturzenegger, Matthias; Mattle, Heinrich P. (2013). Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease. Swiss medical weekly, 143, w13783. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13783 <http://dx.doi.org/10.4414/smw.2013.13783>

Palavras-Chave #610 Medicine & health
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

PeerReviewed